An investigation on behalf of investors in Gamida Cell Ltd. (NASDAQ:GMDA) shares over potential wrongdoing at Gamida Cell Ltd. was announced.
San Diego, CA — (SBWIRE) — 01/27/2022 — Certain directors of Gamida Cell Ltd are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Gamida Cell Ltd. (NASDAQ: GMDA) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Gamida Cell Ltd. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Isreal based Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases.
On November 11, 2021, Gamida Cell Ltd provided an update on the Company’s Pre-Biologics License Application (“BLA”) meeting with the U.S. Food and Drug Administration for omidubicel, the Company’s proposed blood cancer treatment. Specifically, Gamida Cell Ltd disclosed that “[t]he FDA requested that Gamida Cell provide revised analysis of the manufacturing data generated at Gamida Cell’s wholly-owned commercial manufacturing facility to demonstrate the comparability to the omidubicel that was produced at the clinical manufacturing sites for the Phase 3 study,” a development that the Company acknowledged would bring a “delay in timing to bring omidubicel to patients after a potential FDA approval[.]”
Those who purchased shares of Gamida Cell Ltd. (NASDAQ: GMDA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit: http://www.sbwire.com/press-releases/gamida-cell-ltd-nasdaqgmda-investor-alert-investigation-over-potential-wrongdoing-1352461.htm
Media Relations Contact